Search

Background and Aim Methods Results Conclusion Multiple clinical trials have been conducted to study the potential benefits of vitamin E for the treatment of metabolic dysfunction‐associated steatotic liver disease (MASLD). Despite available evidence, vitamin E is not widely used. This study aimed to assess the effect of vitamin E on serum markers of liver inflammation, specifically serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, and histology, including resolution of metabolic dysfunction‐associated steatohepatitis (MASH), in adult patients with MASLD.A systematic literature search on randomized controlled trials published in English was conducted using electronic databases. Standardized mean difference (SMD) and mean difference (MD) were used for continuous outcomes, while risk ratio (RR) was used for dichotomous outcomes, with corresponding 95% confidence interval (CI).A total of eight studies were included in the qualitative synthesis while seven studies were included in the meta‐analysis. Vitamin E significantly reduced serum ALT and AST levels with SMD of −0.82 (95% CI, −1.13 to −0.51) and −0.68 (95% CI, −0.94 to −0.41), respectively. Vitamin E significantly reduced steatosis, lobular inflammation, and hepatocyte ballooning with a MD of −0.60 (95% CI, −0.83 to −0.37), −0.34 (95% CI, −0.53 to −0.16), −0.32 (95% CI, −0.53 to −0.12), and increased MASH resolution with a RR of 1.9 (95%CI, 1.20 to 3.02). However, vitamin E did not reduce fibrosis, with a MD of −0.23 (95% CI, −0.51 to 0.05).Vitamin E resulted in significant improvement in serum markers of liver inflammation and histology in patients with MASLD. [ABSTRACT FROM AUTHOR]

With the advancement of in vivo studies and clinical trials, the pathogenesis of neurodegenerative diseases has been better understood. However, gaps still need to be better elucidated, which justifies the publication of reviews that explore the mechanisms related to the development of these diseases. Studies show that vitamin E supplementation can protect neurons from the damage caused by oxidative stress, with a positive impact on the prevention and progression of neurodegenerative diseases. Thus, this review aims to summarize the scientific evidence of the effects of vitamin E supplementation on neuroprotection and on neurodegeneration markers in experimental models. A search for studies published between 2000 and 2023 was carried out in the PubMed, Web of Science, Virtual Health Library (BVS), and Embase databases, in which the effects of vitamin E in experimental models of neurodegeneration were investigated. A total of 5669 potentially eligible studies were identified. After excluding the duplicates, 5373 remained, of which 5253 were excluded after checking the titles, 90 articles after reading the abstracts, and 11 after fully reviewing the manuscripts, leaving 19 publications to be included in this review. Experiments with in vivo models of neurodegenerative diseases demonstrated that vitamin E supplementation significantly improved memory, cognition, learning, motor function, and brain markers associated with neuroregeneration and neuroprotection. Vitamin E supplementation reduced beta-amyloid (Aβ) deposition and toxicity in experimental models of Alzheimer's disease. In addition, it decreased tau-protein hyperphosphorylation and increased superoxide dismutase and brain-derived neurotrophic factor (BDNF) levels in rodents, which seems to indicate the potential use of vitamin E in preventing and delaying the progress of degenerative lesions in the central nervous system. [ABSTRACT FROM AUTHOR]

With the advancement of in vivo studies and clinical trials, the pathogenesis of neurodegenerative diseases has been better understood. However, gaps still need to be better elucidated, which justifies the publication of reviews that explore the mechanisms related to the development of these diseases. Studies show that vitamin E supplementation can protect neurons from the damage caused by oxidative stress, with a positive impact on the prevention and progression of neurodegenerative diseases. Thus, this review aims to summarize the scientific evidence of the effects of vitamin E supplementation on neuroprotection and on neurodegeneration markers in experimental models. A search for studies published between 2000 and 2023 was carried out in the PubMed, Web of Science, Virtual Health Library (BVS), and Embase databases, in which the effects of vitamin E in experimental models of neurodegeneration were investigated. A total of 5669 potentially eligible studies were identified. After excluding the duplicates, 5373 remained, of which 5253 were excluded after checking the titles, 90 articles after reading the abstracts, and 11 after fully reviewing the manuscripts, leaving 19 publications to be included in this review. Experiments with in vivo models of neurodegenerative diseases demonstrated that vitamin E supplementation significantly improved memory, cognition, learning, motor function, and brain markers associated with neuroregeneration and neuroprotection. Vitamin E supplementation reduced beta-amyloid (Aβ) deposition and toxicity in experimental models of Alzheimer’s disease. In addition, it decreased tau-protein hyperphosphorylation and increased superoxide dismutase and brain-derived neurotrophic factor (BDNF) levels in rodents, which seems to indicate the potential use of vitamin E in preventing and delaying the progress of degenerative lesions in the central nervous system.

Foliar spray of antioxidants is a pragmatic approach to combat various effects of salinity stress in agricultural crops. A pot trial was conducted to examine the effect of exogenously applied α-tocopherol (α-Toc) as foliar spray to induce morpho-physiological modulations in two varieties (Noori and Sabzpari) of okra grown under salt stress conditions (0 mM and 100 mM NaCl). After 36 days of salinity treatments, four levels (0, 100, 200 and 300 mg L–1) of α-tocopherol were sprayed. Salt stress significantly reduced root and shoot fresh and dry biomass, photosynthesis rate (A), transpiration rate (E), water use efficiency (A / E), stomatal conductance, internal CO2 concentration (C i )and C i / C a ) , and photosynthetic pigments. Foliar spray of α-tocopherol proved effective in improving the growth of okra by significantly enhancing root dry weight, root length, shoot fresh weight, shoot length, Chl. a , Chl. b , Total chl., β-Car., Total Car., A, E, A /E, C i , and C i / C a , leaf and root Ca2+ and K+ ion content, total soluble sugars, non-reducing sugars and total soluble protein content by significantly reducing root Na+ ion content. The Okra variety Noori performed better than Sabzpari in the examined attributes, and 300 mg L–1 application of α-tocopherol was more pronounced in improving the growth of okra by alleviating salinity effects. Therefore, the use of α-tocopherol (300 mg L–1) as a foliar spray is recommended to improve okra production in saline soils. Salinity stress mitigation by the application of alpha tocopherol in okra. [ABSTRACT FROM AUTHOR]

Foliar spray of antioxidants is a pragmatic approach to combat various effects of salinity stress in agricultural crops. A pot trial was conducted to examine the effect of exogenously applied α-tocopherol (α-Toc) as foliar spray to induce morpho-physiological modulations in two varieties (Noori and Sabzpari) of okra grown under salt stress conditions (0 mM and 100 mM NaCl). After 36 days of salinity treatments, four levels (0, 100, 200 and 300 mg L–1) of α-tocopherol were sprayed. Salt stress significantly reduced root and shoot fresh and dry biomass, photosynthesis rate (A), transpiration rate (E), water use efficiency (A/E), stomatal conductance, internal CO2 concentration (Ci)and Ci/Ca), and photosynthetic pigments. Foliar spray of α-tocopherol proved effective in improving the growth of okra by significantly enhancing root dry weight, root length, shoot fresh weight, shoot length, Chl. a, Chl. b, Total chl., β-Car., Total Car., A, E, A/E, Ci, and Ci/Ca, leaf and root Ca2+ and K+ ion content, total soluble sugars, non-reducing sugars and total soluble protein content by significantly reducing root Na+ ion content. The Okra variety Noori performed better than Sabzpari in the examined attributes, and 300 mg L–1 application of α-tocopherol was more pronounced in improving the growth of okra by alleviating salinity effects. Therefore, the use of α-tocopherol (300 mg L–1) as a foliar spray is recommended to improve okra production in saline soils.

Background Dentigerous cysts (DC) form due to fluid accumulation between the crown of the tooth and the reduced enamel epithelium. Due to the diverse clinical characteristics, such as ambiguity concerning their biological origins and the significance of timely diagnosis and detection of these lesions, researchers are presently motivated to undertake further investigations. The aim of the present study was to assess the amount of serum alpha-tocopherol in patients with DC and compare it with that of normal, healthy individuals. Methods A total sample size of n=34 was included in the current study. Group A, designated as the control group, comprised 17 randomly selected healthy subjects, while Group B, the DC diagnostic group, consisted of 17 patients. Blood samples were collected, and the concentration of vitamin E or alpha-tocopherol was evaluated and expressed in mg/mL. Results Compared to the mean vitamin E level in healthy controls (12.08 ± 1.92 mg/mL), patients with DC showed a statistically significant (p<0.0001) reduction in mean vitamin E levels (5.29 ± 1.01 mg/mL). Conclusion Patients with DC have lower levels of vitamin E than healthy individuals. The reduced concentration of vitamin E can have a role in the extension of cystic volume and thus have an impact on the aggressiveness of pathologic lesions. The therapeutic benefits of vitamin E supplementation in reducing the aggressiveness of DC should be evaluated in future research., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Saveetha Institute Human Ethical Committee issued approval SDC/PhD/07/18/47. The sample population was chosen from the patients seeking treatment for oral conditions at the outpatient Department of Oral Medicine, Radiology, and Oral Surgery at Saveetha Dental College and Hospitals between 2019 and 2021, with an institutional human ethical committee number of SDC/PhD/07/18/47. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Ubayathulla et al.)

Priming with antioxidants like a-tocopherol is a pragmatic method to alleviate salinity effects. In this study, seeds of two okra varieties (Noori and Sabzpari) were primed for 16 h before sowing with a-tocopherol levels [0 (distilled water), 100, 200 and 300 mg L-1] and salinity levels (0 and 100 mMNaCl) were maintained after sowing the seeds in plastic pots. Salt stress reduced the fresh biomass and yield while, increased the antioxidants activities(CAT, GPX, SOD and protease) total soluble sugars, reducing sugars, MDA, H2O2, total soluble proteins, glycinebetaine and free proline contents of tested okra varieties. Whereas non-significant effect of salinity was recorded for non-reducing sugars, ascorbic acid, total phenolics and activity of POD in tested okra varieties. Alpha tocopherol seed priming proved effective in improving root and shoot fresh biomass, yield, sugars, total soluble proteins, glycinebetaine content and activities/concentration of antioxidants (ascorbic acid, total phenolics, GPX, SOD and protease) in both tested varieties under saline regime. Though, no significant alteration was observed on the concentration of MDA, H2O2 and free proline content due to alpha tocopherol seed priming treatment. Among all a-tocopherol levels used inclusively 200 and 300 mg L-1 were more active. In addition, variety Noori performed better than Sabzpari in all traits. [ABSTRACT FROM AUTHOR]

The objective of this study was to evaluate the behavioural parameters and surface temperatures of broilers fed different vitamin E levels. A total of 240 male, day-old Cobb 500® broiler chicks were raised until the seventh day of life, according to the recommendations for the strain, receiving feed with only 50% of vitamin E requirements. At eight days of age, the birds were weighed and standardised, and the treatments distributed in a completely randomised design with four treatments (50, 100, 150 and 200% of vitamin E requirements) and six replicates of ten birds per experimental unit. The variables evaluated were the behavioural parameters of the birds (eating, drinking, idleness and other activities) and the feed intake within 24 hours as well as the maximum and minimum surface temperatures, and thermal amplitudes at the end of each life cycle (21 and 42 days). Vitamin E levels did not influence behavioural parameters or feed intake over 24 hours at 21 and 42 days of age. There was no interaction between vitamin E levels and maximum and minimum temperatures or thermal amplitudes. However, the maximum and minimum temperatures and thermal amplitudes were influenced by the morning and afternoon periods at 21 and 42 days of age. Dietary vitamin E levels did not influence the behavioural patterns of broilers at 21 and 42 days of age.

Background and Aims: The accumulation of fat increases the formation of lipid peroxides, which are partly scavenged by alpha-tocopherol (α-TOH). Here, we aimed to investigate the associations between different measures of (abdominal) fat and levels of urinary α-TOH metabolites in middle-aged individuals.Methods and Results: In this cross-sectional analysis in the Netherlands Epidemiology of Obesity study (N = 511, 53% women; mean [SD] age of 55 [6.1] years), serum α-TOH and α-TOH metabolites from 24-h urine were measured as alpha-tocopheronolactone hydroquinone (α-TLHQ, oxidized) and alpha-carboxymethyl-hydroxychroman (α-CEHC, enzymatically converted) using liquid-chromatography-tandem mass spectrometry. Body mass index and total body fat were measured, and abdominal subcutaneous and visceral adipose tissue (aSAT and VAT) were assessed using magnetic resonance imaging. Using multivariable-adjusted linear regression analyses, we analysed the associations of BMI, TBF, aSAT and VAT with levels of urinary α-TOH metabolites, adjusted for confounders. We observed no evidence for associations between body fat measures and serum α-TOH. Higher BMI and TBF were associated with lower urinary levels of TLHQ (0.95 [95%CI: 0.90, 1.00] and 0.94 [0.88, 1.01] times per SD, respectively) and with lower TLHQ relative to CEHC (0.93 [0.90, 0.98] and 0.93 [0.87, 0.98] times per SD, respectively). We observed similar associations for VAT (TLHQ: 0.94 [0.89, 0.99] times per SD), but not for aSAT.Conclusions: Opposite to our research hypothesis, higher abdominal adiposity was moderately associated with lower levels of oxidized α-TOH metabolites, which might reflect lower vitamin E antioxidative activity in individuals with higher abdominal fat instead. [ABSTRACT FROM AUTHOR]

It is well known that graphene (G), graphene oxide (GO) and reduced graphene oxides (RGO) are materials of today with immense application potentials. However, to realize the same large scale, reproducible, sustainable synthesis techniques such as greener methods which avoid utilization of toxic chemicals for synthesis, must be adopted. It is in this context, that here we report the reduction of GO to RGO by the extract of Thuja Orientalis (TO) seeds. As such, TO is a well-known bio-resource for medicinal and various other biotechnological applications as it contains Alpha Tocopherol, the major constituent of vitamin E. To the best of our knowledge, despite the wealth of literature, the current work makes a pioneering effort in applying TO seeds extract for reduction of GO to RGO. Thus, the reduction of GO, synthesized by the well-known modified Hummer's method to RGO by TO extract, is confirmed from the results obtained by ultra-violet visible (UV–Vis) spectroscopy, Fourier transform infrared (FTIR) spectroscopy, transmission electron microscopy (TEM), high resolution transmission electron microscopy (HRTEM), energy dispersive X-ray (EDX) analysis, selected area electron diffraction (SAED), Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), atomic force microscopy (AFM) and especially, gas chromatograph mass spectrometry (GCMS) techniques. Furthermore, the GCMS study is used to identify the compound Alpha Tocopherol responsible for reduction of GO to RGO. Based on current experimental evidences and literature views, the possible mechanism of reduction is suggested. Finally, the implications of present studies in the perspective of large scale, sustainable synthesis of RGO for various technological applications are discussed. [ABSTRACT FROM AUTHOR]

The Selenium and Vitamin E Cancer Prevention Trial (SELECT) was a randomized, double-blind, placebo-controlled prostate cancer prevention study funded by the National Cancer Institute (NCI) and conducted by the Southwest Oncology Group (SWOG). A total of 35,533 men were assigned randomly to one of the four treatment groups (vitamin E + placebo, selenium + placebo, vitamin E + selenium, and placebo + placebo). The independent Data and Safety Monitoring Committee (DSMC) recommended the discontinuation of study supplements because of the lack of efficacy for risk reduction and because futility analyses demonstrated no possibility of benefit of the supplements to the anticipated degree (25% reduction in prostate cancer incidence) with additional follow-up. Study leadership agreed that the randomized trial should be terminated but believed that the cohort should be maintained and followed as the additional follow-up would contribute important information to the understanding of the biologic consequences of the intervention. Since the participants no longer needed to be seen in person to assess acute toxicities or to be given study supplements, it was determined that the most efficient and cost-effective way to follow them was via a central coordinated effort.A number of changes were necessary at the local Study Sites and SELECT Statistical Center to transition to following participants via a Central Coordinating Center. We describe the transition process from a randomized clinical trial to the observational Centralized Follow-Up (CFU) study.The process of transitioning SELECT, implemented at more than 400 Study Sites across the United States, Canada, and Puerto Rico, entailed many critical decisions and actions including updates to online documents such as the SELECT Workbench and Study Manual, a protocol amendment, reorganization of the Statistical Center, creation of a Transition Committee, development of materials for SELECT Study Sites, development of procedures to close Study Sites, and revision of data collection procedures and the process by which to contact participants.At the time of the publication of the primary SELECT results in December 2008, there were 32,569 men alive and currently active in the trial. As of 31 December 2011, 17,761 participants had been registered to the CFU study. This number is less than had been anticipated due to unforeseen difficulties with local Study Site institutional review boards (IRBs). However, from this cohort, we estimate that an additional 580 prostate cancer cases and 215 Gleason 7 or higher grade cancers will be identified. Over 109,000 individual items have been mailed to participants. Active SELECT ancillary studies have continued. The substantial SELECT biorepository is available to researchers; requests to use the specimens are reviewed for feasibility and scientific merit. As of April 2012, 12 proposals had been approved.The accrual goal of the follow-up study was not met, limiting our power to address the study objectives satisfactorily. The CFU study is also dependent on a number of factors including continued funding, continued interest of investigators in the biorepository, and the continued contribution of the participants. Our experience may be less pertinent to investigators who wish to follow participants in a treatment trial or participants in prevention trials in other medical areas.Extended follow-up of participants in prevention research is important to study the long-term effects of the interventions, such as those used in SELECT. The approach taken by SELECT investigators was to continue to follow participants centrally via an annual questionnaire and with a web-based option. The participants enrolled in the CFU study represent a large, well-characterized, generally healthy cohort. The CFU has enabled us to collect additional prostate and other cancer endpoints and longer follow-up on the almost 18,000 participants enrolled. The utility of the extensive biorepository that was developed during the course of the SELECT is enhanced by longer follow-up.

A 5‐year‐old male neutered domestic shorthair cat suffered from recurrent solitary nodules in different subcutaneous body regions. Nodules were surgically removed and each time histopathological diagnosis was fat necrosis and fibrosing to pyogranulomatous panniculitis. After the second surgery the alpha (α)‐tocopherol concentration in serum of the cat was examined and the result (21 mg/L) exceeded the upper limit of the reference interval (3–11 mg/L). Vitamin E amount in diet fed solely in the past was checked as studies have shown that vitamin E amounts in food significantly influence vitamin E concentrations in serum. For comparative purposes, α‐tocopherol concentrations were determined in sera of healthy control cats. Additionally, vitamin E amount in wet food from different manufacturers was analysed using gas chromatography coupled to mass spectrometry (GC‐MS). The results showed that the diet did not have higher vitamin E amounts compared to other diets. All control cats had similar high serum α‐tocopherol concentrations. We conclude that panniculitis can occur despite high serum α‐tocopherol concentrations in cats. Further studies are needed to redefine reference values of α‐tocopherol in serum of cats. [ABSTRACT FROM AUTHOR]

Background: The effects of α-tocopherol on intracellular Ca2+ intensity in semen cryopreservation by regulate intracellular Ca2+ intensity have not been reported yet. Objective: The research was conducted to evaluate the effect of supplementation α-tocopherol into egg yolk skim milk extender on sperm quality and intracellular Ca2+ intensity. Methods: Semen samples were collected and supplemented with respectively 0mM (P0); 0.5mM (P1); 1mM (P2); 1.5mM (P3) and 2mM (P4) α-tocopherol in extender before cryopreservation processes. Post-thawing sperm was evaluated for motility, viability, and abnormality using Phase Contrast Microscope (200x) with eosin-nigrosine staining, and intracellular Ca2+ intensity of the best result dose was evaluated using Confocal Laser Scan Microscope (400x) with Fluo-3 Staining. Results: The results showed there was a significant difference (P≤0.05) in sperm motility and viability between P0; P1 with P2; P3; P4. The Motility and viability between groups P0; P1 and P3; P4 showed no significant difference (P≥0.05), while P2 with P3; P4 showed significant difference (P≤0.05). There was a significant difference (P≤0.05) in sperm abnormality of P0; P1 with P2; P3; P4. The abnormality between P0; P1 and P2; P3 showed no significant difference (P≥ 0.05), while P2; P3 showed a significant difference with P4 (P≤0.05). The best result in sperm quality was supplementation with 1.5mM α-tocopherol. Ca2+ intracellular intensity: 142.76 ± 21.8 au (P0) and 176.06 ± 61.43 au (P3). Conclusions: It was concluded that 1.5mM α-tocopherol is the best dose to improve sperm quality by regulating intracellular Ca2+ intensity on Simmental bull cattle.

A field experiment was carried out during the spring season of 2018 in the station (A) - Department of Horticulture and Gardening Landscape - College of Agriculture Engineering Sciences, University of Baghdad-Al-Jadriya. In order to study the effect of organic, chemical fertilizers and spraying of alpha-tocopherol on growth and yield of tomato (Hybrid Sereen). The experiment included two factors, the first factor was used different types of fertilizers which included the chemical fertilizers according to the recommendation N: 120, P2O5: 150 and K2O: 120 kg ha-1 (T1) it was added in two batches, and the organic fertilizer of the cows manure at 30 ton ha-1(T2), It was added before planting. The Organic Fertilizer Manufacturer (Care Ball supermix) added in two levels, each level being as fertilizer treatment, 20 kg per 1000 m² (T3), the second level is 40 kg per 1000 m2 (T4), as well as the control treatment (T0). The second factor was spraying the alpha tocopherol with two levels. The first level is the spraying alpha tocopherol at concentration of 100 mg L-1 (E1), the second level was spraying alpha tocopherol at concentration of 200 mg L-1 (E2), in addition to the control treatment, which sprayed with distilled water only (E0). Results showed the treatment T2 traits superior in all vegetative growth of plant: height plant, number of branches, number of leaves, leaf area and dry weight of vegetative growth, Also excelled (T2) of the number of fruits, highest yield per plant and total yield, while the treatment T1 gave highest of weight of the fruit. In addition, the foliar spraying of alpha tocopherol showed significant superiority in treatment (E2) in all traits of vegetative growth and yield characteristics. Treatment T2E2 gave the highest plant length (145.3 cm), greatest number of plant branches (16.84 branch Plant-1), highest number of leaves (138.7 Leaf Plant-1), largest leaf area (264.7 dcm2Plant-1), highest dry weight of vegetative growth (233.6 g Plant-1), highest number of fruits and highest yield per plant and total yield (40.55 fruit Plants-1, 3.99 kg Plants-1 and 66.33 ton ha-1 respectively). While treatment T1E2 was superior by giving the highest fruit weight (111.8 g fruit-1). The suggestion could be that using cow manure (organic fertilizer) 30 ton ha-1 and foliar spraying of alpha tocopherol in concentration 200 mg L-1, resulted in highest of vegetative growth and yield. [ABSTRACT FROM AUTHOR]

Pregabalin abuse has become an emerging concern; thus, the current study has been designed to study the neurotoxic hazards of prolonged high-dose of pregabalin (akin to that abused by addicts) and to evaluate the effect of alpha tocopherol as a possible ameliorating agent. The current study evaluated the brain neurotransmitters; dopamine, glutamate, and norepinephrine. The study also assessed the expression of the apoptosis-related markers Bax, Bcl2, and caspase 3. Western-blotted analysis of the three major mitogen-activated protein kinases (MAPKs), the c-JUN N-terminal kinase (JNK), the p38 MAPK, and the extracellular signal-regulated kinase (ERK), has also been performed. The study also evaluated oxidative stress via assessment of the cortical tissue levels of reduced glutathione and malondialdehyde and the activity of superoxide dismutase. Histopathological examination and histomorphometric evaluation of the darkly degenerated cortical neurons have also been performed. Pregabalin in high doses (150 mg/kg/day and 300 mg/kg/day) disrupted the ERK/JNK/p38-MAPK signaling, reversed the bax/bcl2 ratio, and induced oxidative stress. It also diminished the release of dopamine, glutamate, and norepinephrine and increased the count of degenerated neurons. Alpha tocopherol treatment significantly attenuated the deleterious effects induced by pregabalin. The role of alpha tocopherol in ameliorating the oxidative stress injury, and apoptosis induced by pregabalin, along with its role in normalizing neurotransmitters, modulating the ERK/JNK/p38-MAPK signaling pathways and improving the histopathological cortical changes, offers alpha tocopherol as a promising adjunctive therapy in patients undergoing prolonged pregabalin therapy as those suffering from prolonged seizures and neuropathies. [ABSTRACT FROM AUTHOR]

Introduction: Contrast induced nephropathy (CIN), a well-known complication of using radio contrast media, dramatically increases the likelihood of patient morbidity and mortality following coronary angiography. As there is no specific treatment for CIN, prevention could be the best strategy to address this issue. Since now, the only approved preventing strategy was hydration with normal saline while antioxidant agents as a new yet unapproved remedy for this purpose could be applied .The present study was conducted to examine the effect of alpha tocopherol in CIN prevention.Methods: This prospective controlled trial was carried out on 201 patients with chronic kidney disease (eGFR < 60 cc/min) underwent coronary angiography. We assigned three groups of CKD patients: 72 patients who received prophylaxis administration with isotonic saline (Group A), 66 patients with isotonic saline plus N-acetylcysteine (1200mg twice a day) for 2 days (Group B) and 63 patients who received isotonic saline plus daily alpha tocopherol (600 IU once daily from one day before till 2 days after angiography) for 4 days (Group C). The contrast media in all three groups was nonionic iso-osmolal agent, Visipaque.Results: Even though CIN didn't developed in any of the three aforementioned groups but there was statistically significant reduction in eGFR from baseline in all three groups (P < .001). Moreover, We found no statistically significant difference in GFR reduction between three studied groups.Conclusion: Administration of alpha tocopherol has no additive beneficial effect over isotonic saline in CIN prevention in CKD patients. [ABSTRACT FROM AUTHOR]

Vitamin E is an important lipid-soluble antioxidant that is tied to normal neuromuscular function in adult horses. Deficiency in serum vitamin E concentrations have been associated with several equine diseases such as Equine Motor Neuron Disease and Equine degenerative myeloencepalopathy. Horses with restricted access to pasture and genetic predispositions, like the Morgan Horse, can be especially susceptible to being marginally low or deficient. Two types of supplemental forms of Vitamin E are available: natural form, d-alpha-tocopherol acetate, and a synthetic form, dl-alpha-tocopherol, with the natural form being more expensive for horse owners. The objective of this study was to compare the serum vitamin E concentrations of horses on a low dose of natural (d-alpha) versus synthetic (dl-alpha) vitamin E. Eight horses with marginal/deficient serum alpha-tocopherol (0.94 - 2.3 μg/mL) were enrolled in a randomized block design study. Blocks were balanced for age, body weight and pre-study vitamin E level and were assigned to one of two treatments. 1) NATURAL - 2,000 IU powder (d-alpha-tocopherol acetate) for 16 wk. 2) SYNTHETIC - 2,000 IU dl-alpha tocopherol acetate for 16 wk. Horses were housed in box stalls with daily turnout without access to grass. Horses were fed hay at 2% of BW and 0.45 kg of concentrate daily with vitamin E feed activity of 45.5 and 1,378 IU/kg, respectively. Natural and synthetic treatments were fed once daily with the AM feeding. To ensure horses consumed the powder d-alpha-tocopherol acetate and capsules of dl-alpha-tocopherol acetate, cookies made from alfalfa powder, gelatin and d-alpha-tocopherol acetate powder were created. Serum alpha-tocopherol was assessed pre-feeding every four weeks from 0 to 16 weeks. Overall, horses supplemented with synthetic treatment had higher serum alpha-tocopherol than those supplemented with the natural treatment (2.61 vs 2.34, respectively; SE = 0.08, P = 0.05). Both treatments increased serum alpha-tocopherol concentrations to normal ranges (2.0-4.0 μg/mL) for all horses by 4 weeks and maintained the normal concentrations with the exception of week 12 for horses receiving the natural supplement compared with the synthetic (1.81 vs 2.62 μg/mL). Because of this diversion, there tended to be a week x treatment interaction (P = 0.06). The results of this study indicate the use of a synthetic, more affordable Vitamin E supplement will increase serum alpha-tocopherol concentrations similarly to natural supplements. However, further research is needed to determine how these supplements are utilized within the body. [ABSTRACT FROM AUTHOR]

Vitamin E is an important antioxidant for normal neuromuscular function in horses. Dietary deficiencies are common in northern climates with seasonal access to pastures. Certain breeds, such as Morgan Horses, with predisposition to equine metabolic diseases, may exhibit deficiencies in vitamin E because of management systems imposed which restrict access to pasture. Few studies have compared strategies for initial supplementation to increase serum alphatocopherol in horses. The objective of this study was to compare two dosing strategies of d-alpha-tocopherol acetate to increase serum alpha-tocopherol in marginal/deficient horses. Eight Morgan horses (two geldings, six mares; mean BW = 460 kg) with marginal/deficient serum alpha-tocopherol (0.47-1.12 μg/mL) were enrolled in a randomized block design study. Blocks were balanced for age, sex, and pre-study vitamin E level and horses were assigned to one of two treatments: 1) HIGH - 10,000 IU liquid d-alpha-tocopherol acetate top-dressed on grain for 4 wk followed by 10 d step-down to 5,000 IU of powder d-alpha-tocopherol acetate through 16 wk; or MEDIUM - 5,000 IU of powder d-alpha-tocopherol acetate for 16 wk. Horses were housed in box stalls with daily turnout without access to grass. Horses were fed hay at 2% of BW and 0.45 kg of concentrate daily with vitamin E feed activity of 45.5 and 1378 IU/kg, respectively. HIGH and MEDIUM treatments were fed once daily with the AM feeding. To ensure horses consumed the powder d-alpha-tocopherol acetate, cookies made from alfalfa powder, gelatin and d-alpha-tocopherol acetate powder were created. Serum alpha-tocopherol was assessed pre-feeding every two weeks from 0 to 16 weeks. Before the step-down to 5,000 IU dose, horses receiving the HIGH dosage had greater concentrations of serum alpha-tocopherol (P < 0.01; Figure 1). All horses receiving the HIGH treatment attained serum alphatocopherol concentrations greater than 2.0 μg/mL after 2 weeks, while only one-half of horses receiving the MEDIUM dosage reached serum alpha-tocopherol concentrations greater than 2.0 μg/mL by 4 weeks. To attain and maintain normal concentrations of serum alpha-tocopherol, deficient horses should follow the HIGH supplementing strategy of d-alpha-tocopherol acetate. [ABSTRACT FROM AUTHOR]

Background & objectives: Ischemic stroke has complex pathophysiology and its treatment with single neuroprotective drugs has so far failed. Combination therapy could produce amplified protective effects via different mechanisms. We examined the neuroprotective effects of enalapril and/or alpha tocopherol against sensorimotor dysfunctions of ischemic stroke. Methods: Forty male Sprague-Dawley rats were randomly divided into five groups (n=8): sham, control ischemic, enalapril (0.03 mg/kg), alpha tocopherol (30mg/kg) and enalapril plus alpha tocopherol treated groups. Transient focal cerebral ischemia (90 min) was induced by occlusion of the left middle cerebral artery that followed by 24 h reperfusion periods. Infarct volumes were detected by TTC coloring technique and sensorimotor dysfunctions investigated by rotarod, grip strength and hotplate tests. Results: Induction of cerebral ischemia in the control group produced severe neurological sensorimotor deficits in conjunction with considerable cerebral infarctions. Compared with the enalapril or alpha tocopherol groups, the combined treatment significantly improved neurological motor and sensory functions (p=0.038 and p=0.034, respectively) and also reduced the infarct volume (p=0.032). Conclusion: Administration of alpha tocopherol increased protective effects of enalapril. Enalapril combined with alpha tocopherol can produce an augmented protection against ischemic brain injury, and improvement in sensorimotor dysfunctions.

The objective of the present study was to ascertain the effect of in ovo feeding of vitamin E (VE) on the incubation results, quality, and oxidative state of newborn chicks and on the initial performance results. The design consisted of randomized blocks with treatments at different levels of VE (0.0, 27.5, 38.5, 49.5, and 60.4 IU). On 17.5 d of embryonic development, 780 eggs underwent in ovo injection using a manual needle. VE supplementation of 60.4 IU provided the highest hatching rate (P < 0.05) and shortest hatch window (P < 0.05). Better results regarding chick physical quality were observed in groups supplemented with VE (body weight, length, newborn chick quality score) and higher chick weight/egg weight ratios (P < 0.05). VE inoculation did not have any effect on the chicks' immunological system (P > 0.05). Greater development of the small intestine (intestine weight/yolk free chick weight and higher villi in duodenum) and better feed conversion over all periods studied (1 to 7, 1 to 14, and 1 to 21 d) were observed among chicks that received in ovo VE supplementation (P < 0.05). The total protein concentrations in the liver and striated breast skeletal muscle tissue were highest in chicks that received 60.4 IU of VE (P < 0.05). The highest catalase activity was observed in the livers of newborn chicks supplemented with 60.4 IU of VE (P < 0.05). It was concluded that in ovo VE supplementation improved the chicks' oxidative state, which led to improvements in incubation results, chick quality and performance results. [ABSTRACT FROM AUTHOR]

The aim of the present study was to evaluate the in vivo antioxidant activity of 50% ethanolic extract of Linum usitatissimum against high fat diet induced rats. Animals were treated with plant extract for 30 days, and high fat diet was given to all groups except plain control through, out the study, and alpha tocopherol acetate (Vit, E) was used as standard. pre-treatment with 23 mg/100 gm of body weight of 50% ethanolic extract of Linum usitatissimum significantly improved the superoxide dismutase, catalase, glutathione, and lipid peroxidation levels as compared to control group. The present studies revealed that the in vivo antioxidant activity of Linum usitatissimum was significant, and can be used to protect tissue from oxidative stress. The result showed that the superoxide dismutase, catalase, lipid peroxidase, and glutathione reductase activities significantly declined in group treated with high fat diet than that of normal group. Based on this investigation, it was concluded that the 50% ethanolic extract of Linum usitatissimum has good in vivo antioxidant activity and can be used in protecting tissue from oxidative stress. [ABSTRACT FROM AUTHOR]

Mild to moderate vitamin E deficiency because of inadequate consumption of vitamin E-rich foods and intestinal fat malabsorption is common in growing children, women of reproductive age and elderly South Asian population. Severe vitamin E deficiency may lead to peripheral and motor neurodegenerative diseases (e.g ataxia and motor skeletal myopathy), impaired immune response and free radical-induced hemolytic anemias. Vitamin E insufficiency and/or deficiency status in the general Pakistani population has not been sufficiently investigated. Moreover, there are challenges in determining vitamin E status in apparently healthy humans due to variations in their age, sources of consumed vitamin E and plasma lipid levels. Oxidative stress-induced reactive oxygen species have been shown to cause ineffective erythropoiesis and enhanced lysis of erythrocytes in some of the experimental animals and humans. Several studies on patients with various types of inherited hemolytic anemias, chronic renal disease, premature low birth infants and apparently healthy humans have shown that vitamin E might be therapeutically effective in the prevention and/ or treatment of anemia in these subjects. [ABSTRACT FROM AUTHOR]

Background & objectives: Stroke is third leading cause of death and disability in the most of human communities. Several experimental studies have shown that combination therapy with drugs that act via different mechanisms can produce amplified protective effects. We examined the effects of combination therapy with candesartan and alpha tocopherol against cerebral ischemia. Methods: Male Sprague-Dawley rats were divided into five groups (n=24): sham, control ischemic, candesartan treated (0.3 mg/kg), alpha tocopherol treated (30 mg/kg) and combined treated ischemic groups. Transient focal cerebral ischemia was induced by 90-min-long occlusion of the left middle cerebral artery followed by 24-h-long reperfusion. Neurological deficit score was evaluated at the end of the reperfusion period. Thereafter, the animals were randomly used for measurement of the infarct volumes and investigation of ischemic brain edema formation using a wet/dry method. Results: Induction of cerebral ischemia produced considerable brain infarction in conjunction with severely impaired motor functions and edema formation. Combined treatment with candesartan and alpha tocopherol significantly reduced the infarct volume and lowered the water content in the ischemic lesioned hemisphere. These effects on brain edema and oxidative stress biomarkers were significantly more than the monotherapy with candesartan. Conclusion: The combination therapy with candesartan and alpha tocopherol can noticeably decrease ischemic brain injury and attenuate edema formation likely via increasing the antioxidant activity.

Several epidemiological reports and experimental investigations have suggested a preventive role for folic acid in the etiology of cervical cancer. The effect of p.o. folic acid supplementation on the natural history of cervical intraepithelial neoplasia (CIN) was evaluated in a multiinstitutional prospective, randomized, double-blind, placebo-controlled trial. Three hundred thirty-one women with biopsy-proven koilocytic atypia, mild CIN, or moderate CIN were randomized to receive oral folic acid (5 mg) or a similar-appearing placebo daily for 6 months following a 1-month run-in placebo period. Colposcopy, Papanicolaou smear, and serum vitamin levels (folate, retinol, alpha-tocopherol, beta-carotene, and retinyl palmitate) were monitored every 3 months. Demographic, medical, dietary, and sexual history data were obtained from personal interviews. The primary end point of the study was improvement in both Papanicolaou smear and colposcopic picture after 3 and 6 months of treatment as compared to the start of treatment. After 6 months of treatment there was no significant difference between the two study groups in the percentage of patients improved. Median serum folate levels in the treatment arm at 3 and 6 months (29.0 and 20.0 micrograms/dl) were significantly higher than those in the placebo arm (7.8 and 7.1 micrograms/dl, respectively). Mean serum levels of retinol, retinyl palmitate, alpha-tocopherol, and beta-carotene did not differ significantly between the two treatment arms. Our data support the conclusion that supplementation with folic acid (5 mg/day) does not enhance the regression of early epithelial abnormalities of the cervix.(ABSTRACT TRUNCATED AT 250 WORDS)

The most convincing evidence for a preventive role for any modality is obviously demonstration of incidence reduction produced by that modality. However, cancer prevention trials with cancer incidence as an endpoint have logistic problems rendering them essentially impossible to conduct for most malignancies. Hence a workable strategy often involves analysis of other, indirect lines of evidence to reach conclusions. For oral cancer, dietary epidemiologic evidence points to a protective role for foods rich in carotenoids. Other anti-oxidants, such as vitamin C, are also implicated. Similarly, laboratory evidence points to a carcinogenesis inhibitory role for both retinoids and carotenoids. Clinical studies have targeted premalignant lesions, i.e., oral leukoplakia. For over two decades the efficacy of retinoids, natural and synthetic, has been known. Nevertheless, it has been difficult to translate this into a recommendation for prevention because of the toxicity of retinoids. The synthetic retinoid most often used in these trials is 13-cis-retinoic acid. This compound is toxic even at very low doses (0.1 mg/kg/day), particularly when given over several weeks to months. Hence, although effective, it cannot be advocated for prevention or oral cavity cancer. Studies with nontoxic antioxidants, such as beta-carotene, are much more recent. Early results are promising in that beta-carotene, alone or in combination with other nutrients, can reverse oral leukoplakia without toxicity in short-term trials. Studies currently under way will demonstrate whether durable remissions can be obtained using this strategy. It should be emphasized that such long-term trials are problematic to conduct with the toxic retinoids because the risks of prolonged exposure to them outweighs the chance of cancer development in the usual leukoplakia lesion.

An amphiphilic chitosan salt, chitosan oleate (CS-OA), was previously proposed for the physical stabilization of lemongrass antimicrobial nanoemulsions (NE) through a mild spontaneous emulsification process. As both chitosan and oleic acid are described in the literature for their positive effects in wound healing, in the present study CS-OA has been proposed to encapsulate alpha tocopherol (αTph) in NEs aimed to skin wounds. A NE formulation was developed showing about 220 nm dimensions, 36% drug loading, and αTph concentration up to 1 mg/ml. Both CS-OA and αTph NE stimulated cell proliferation on keratinocytes and fibroblast cell cultures, and in ex vivo skin biopsies, suggesting the suitability of CS-OA and of the antioxidant agent for topical application in wound healing. αTph stability was further improved with respect of encapsulation, by spray drying the NE into a powder (up to about 90% αTph residual after 3 months). The spray drying process was optimized, to improve powder yield and αTph recovery, by a design of experiments approach. The powder obtained was easily re-suspended to deliver the NE and resulted able to completely release αTph. [ABSTRACT FROM AUTHOR]

We, herein, investigated the in vitro effects of argininic acid on thiobarbituric acid-reactive substances (TBA-RS), total sulfhydryl content and on the activities of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in the blood, kidney and liver of 60-day-old rats. We also verified the influence of the antioxidants (each at 1.0 mM) trolox and ascorbic acid, as well as of N G -nitro- l -arginine methyl ester (L-NAME) at 1.0 mM, a nitric oxide synthase inhibitor, on the effects elicited by argininic acid on the parameters tested. The liver, renal cortex and renal medulla were homogenized in 10 vol (1:10w/v) of 20 mM sodium phosphate buffer, pH 7.4, containing 140 mM KCl; and erythrocytes and plasma were prepared from whole blood samples obtained from rats. For in vitro experiments, the samples were pre-incubated for 1 h at 37 °C in the presence of argininic acid at final concentrations of 0.1, 1.0 and 5.0 μM. Control experiments were performed without the addition of argininic acid. Results showed that argininic acid (5.0 μM) enhanced CAT and SOD activities and decreased GSH-Px activity in the erythrocytes, increased CAT and decreased GSH-Px activities in the renal cortex and decreased CAT and SOD activities in the renal medulla of 60-day-old rats, as compared to the control group. Antioxidants and/or L-NAME prevented most of the alterations caused by argininic acid on the oxidative stress parameters evaluated. Data suggest that argininic acid alters antioxidant defenses in the blood and kidney of rats; however, in the presence of antioxidants and L-NAME, most of these alterations in oxidative stress were prevented. These findings suggest that oxidative stress may be make an important contribution to the damage caused by argininic acid in hyperargininemic patients and that treatment with antioxidants may be beneficial in this pathology. [ABSTRACT FROM AUTHOR]

Astrocytes are known as structural and supporting cells in the central nervous system (CNS). Glutamate, as a main excitatory amino acid neurotransmitter in the mammalian central nervous system, can be excitotoxic, playing a key role in many chronic neurodegenerative diseases. The aim of the current study was to elucidate the potential of vitamin E in protecting glutamate-injured primary astrocytes. Hence, primary astrocytes were isolated from mixed glial cells of C57BL/6 mice by applying the EasySep® Mouse CD11b Positive Selection Kit, cultured in Dulbecco's modified Eagle medium (DMEM) and supplemented with special nutrients. The IC20 and IC50 values of glutamate, as well as the cell viability of primary astrocytes, were assessed with 100 ng/mL, 200 ng/mL, and 300 ng/mL of tocotrienol-rich fraction (TRF) and alpha-tocopherol (α-TCP), as determined by an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The mitochondrial membrane potential (MMP) detected in primary astrocytes was assessed with the same concentrations of TRF and α-TCP. The expression levels of the ionotropic glutamate receptor genes (Gria2, Grin2A, GRIK1) were independently determined using RT-PCR. The purification rate of astrocytes was measured by a flow-cytometer as circa 79.4%. The IC20 and IC50 values of glutamate were determined as 10 mM and 100 mM, respectively. Exposure to 100 mM of glutamate in primary astrocytes caused the inhibition of cell viability of approximately 64.75% and 61.10% in pre- and post-study, respectively (p < 0.05). Both TRF and α-TCP (at the lowest and highest concentrations, respectively) were able to increase the MMP to 88.46% and 93.31% pre-treatment, and 78.43% and 81.22% post-treatment, respectively. Additionally, the findings showed a similar pattern for the expression level of the ionotropic glutamate receptor genes. Increased extracellular calcium concentrations were also observed, indicating that the presence of vitamin E altered the polarization of astrocytes. In conclusion, α-TCP showed better recovery and prophylactic effects as compared to TRF in the pre-treatment of glutamate-injured primary astrocytes. [ABSTRACT FROM AUTHOR]

Background Lycopene is a naturally occurring compound classified as a carotenoid, a group of pigments responsible for the vibrant colors observed in many fruits and vegetables. It is most commonly associated with red-colored fruits and vegetables, such as tomatoes, watermelon, pink grapefruit, and papaya. Vitamin E encompasses a group of chemical compounds that share a structural relationship with alpha-tocopherol and are essential for the proper functioning of the human body. It is a fat-soluble vitamin and is known for its antioxidant properties. The aim of this study is to evaluate the antimicrobial activity of lycopene extract, vitamin E extract, and their combination against oral pathogens for their potential application in the treatment of oral diseases. Materials and methods The potential antimicrobial effects of extracts derived from lycopene, vitamin E, and their combination were evaluated against oral commensals like Staphylococcus aureus , Streptococcus mutans , Enterococcus faecalis , and Candida albicans . Three concentrations (25 μl, 50 μl, and 100 μl) of the extract were tested. Mueller-Hinton agar (MHA) and Rose Bengal agar (RBA) bases were utilized to determine the zone of inhibition. And the experiments were repeated in triplicate for each group. Results The identification and assessment of the antimicrobial activity of lycopene extract, vitamin E extract, and their combination revealed the greatest efficacy at the highest concentration (100 μl) against all tested microbial strains. Notably, C. albicans exhibited the highest susceptibility compared to the other strains. Vitamin E had the least antimicrobial effect and combination had the highest antimicrobial effect. Conclusion The results of our study demonstrated substantial antimicrobial activity of lycopene and vitamin E. These findings suggest that lycopene and vitamin E can be harnessed in the development of diverse drug formulations for the treatment of oral diseases., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Divyadharsini et al.)

In this study was to extract and analyses composition of corn oil and develop cosmetics from corn oil extract. A simple high performance liquid chromatographic procedure for the determination of retinol and alpha tocopherol from corn oil nanoemulsions was proposed. The preparation condition for nanoemulsions of corn oil by high pressure homogenization was investigated. It appeared that the appropriate number of homogenization cycle was 8 cycles under the pressure of 1,000 bars at 25±C for the formula which contained 40% of corn oil, 15% of the mixed surfactant between Tween 80 and Span 80. The droplet sizes of the corn oil nanoemulsions were found to be 115.5±0.6 nm. The HPLC method was developed and validated for various chromatographic conditions for simultaneous determination of retinol and alpha tocopherol in corn oil nanoemulsion. The sample was analyzed on an Inersil C8-3 (4.6 mm×150 mm), using methanol and water as mobile phase with gradient elution system and detected at 292 and 325 nm for alpha tocopherol and retinol, respectively by spectrophotometer. The flow rate was used at 1 mL min-1 to complete separation of both analyzes. Under the optimum conditions, retinol and alpha tocopherol could be determined within a concentration range of 5-40 μg mL-1 which can be expressed by the regression equation y = 57507x+136421 (r2 = 0.9990) and y = 10434x+26394 (r2 = 0.9980), respectively. The limit of detection and quantitation were found to be 0.063 and 0.192 μg mL-1 for retinol and 0.067 and 0.203 μg mL-1 for alpha tocopherol, respectively. The proposed method was applied to the determination of retinol and alpha tocopherol contents in corn oil nanoemulsions. [ABSTRACT FROM AUTHOR]

Ototoxicity is a known side effect of cisplatin chemotherapy due to formation of free radicals causing death to cochlear outer hair cells, resulting in hearing loss. Alpha tocopherol has otoprotective effects towards cisplatin in animal studies. Further human studies are needed. The objective of this study was to measure hearing function to know the otoprotective effects of alpha tocopherol against cisplatin. A randomized control trial was performed at Dr. Hasan Sadikin Hospital Bandung in December 2011–February 2012 in 2 groups. The treatment group received standard cisplatin chemotherapy treatment and alpha tocopherol 400 International Unit (IU)/day since day 1 before a 30-day-treatment. the control group received standard cisplatin chemotherapy treatment. Hearing evaluation was done using tympanometry, audiometry and distortion product otoacoustic emission (DPOAE) before and after the first and second cycles of chemotherapy. Results showed that ototoxic incidence after the first cycle of chemotherapy was significantly lower in group 1 (33.3%) than group 2 (66.7%) (p=0.046, CI=95%). Ototoxic incidence after the second cycle of chemotherapy was significantly lower in group 1 (50%) than group 2 (88.9%) (p=0.027, CI=95%). In conclusion, oral alpha tocopherol 400 IU can prevent cisplatin-induced ototoxicity.

Estudios epidemiologicos han demostrado el efecto del estado nutricional de los tocoferoles y el desarrollo de enfermedades cardiovasculares, las cuales son cada vez mas frecuentes en edades tempranas de la vida. Este trabajo relaciona el colesterol total con las concentraciones sericas de tocoferoles en una poblacion de ninos mexicanos, evaluando ademas su estado antioxidante y oxidante. De octubre a diciembre de 2003, se cuantifico en suero a-tocoferol, γ-tocoferol y colesterol total en 1155 niños (12-59 meses) residentes de localidades urbanas y rurales; se evaluo la capacidad antioxidante y el estado oxidante con la produccion de TBARS. Los ninos con cifras de colesterol > 240 mg/dL fue de 577.3 ± 200.8 μg/dL. Sin embargo, cuando se expresaron los tocoferoles en relacion con el colesterol total (μmol/mmol), se observo que los niños con + 1.19), lo que los ubicaba en un adecuado estado nutricional de a-tocoferol, a diferencia del grupo con > 240 mg/dL de colesterol en quienes la relacion fue baja (1.93 ± 0.69). No se observaron diferencias en la capacidad antioxidante del suero, pero si en la produccion de TBARS para los niños con > 200 mg/dL de colesterol. En preescolares los incrementos en el colesterol total limitan la disponibilidad de tocoferoles sericos para los lipidos circulantes, esta condicion a traves del tiempo puede condicionar el desarrollo prematuro de lesiones vasculares mediadas por estres oxidativo.Epidemiological studies have shown the effect of nutritional status of tocopherols and development of cardiovascular diseases that now are more frequent during early years of life. In this work we evaluated the association between the total cholesterol and serum levels of tocopherols in a population of Mexican children in whom we measured the oxidant status and antioxidant capacity (December 2003). In 1155 children (12-59 months) residents of urban and rural locations we quantified in serum a-tocopherol, γ-tocopherol and total cholesterol; the antioxidant capacity and oxidative status were evaluated with the production of TBARS. Children with serum cholesterol > 240 mg/dL cholesterol recorded an average of 577.3 ± 200.8 μg/dL. However, when tocopherols were expressed in relation to total cholesterol (μmol/mmol) found that children with > 240 mg/dL of cholesterol in whom the relationship was low (1.93 ± 0.69). There were no differences in serum antioxidant capacity, but if in the production of TBARS for children with > 200 mg/dL cholesterol. In preschools the increases in total cholesterol limits the availability of serum tocopherol for circulating lipids, this condition over time could determine the early development of vascular injury mediated by oxidative stress.

Astrocytes are known as structural and supporting cells in the central nervous system (CNS). Glutamate, as a main excitatory amino acid neurotransmitter in the mammalian central nervous system, can be excitotoxic, playing a key role in many chronic neurodegenerative diseases. The aim of the current study was to elucidate the potential of vitamin E in protecting glutamate-injured primary astrocytes. Hence, primary astrocytes were isolated from mixed glial cells of C57BL/6 mice by applying the EasySep® Mouse CD11b Positive Selection Kit, cultured in Dulbecco’s modified Eagle medium (DMEM) and supplemented with special nutrients. The IC20 and IC50 values of glutamate, as well as the cell viability of primary astrocytes, were assessed with 100 ng/mL, 200 ng/mL, and 300 ng/mL of tocotrienol-rich fraction (TRF) and alpha-tocopherol (α-TCP), as determined by an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The mitochondrial membrane potential (MMP) detected in primary astrocytes was assessed with the same concentrations of TRF and α-TCP. The expression levels of the ionotropic glutamate receptor genes (Gria2, Grin2A, GRIK1) were independently determined using RT-PCR. The purification rate of astrocytes was measured by a flow-cytometer as circa 79.4%. The IC20 and IC50 values of glutamate were determined as 10 mM and 100 mM, respectively. Exposure to 100 mM of glutamate in primary astrocytes caused the inhibition of cell viability of approximately 64.75% and 61.10% in pre- and post-study, respectively (p < 0.05). Both TRF and α-TCP (at the lowest and highest concentrations, respectively) were able to increase the MMP to 88.46% and 93.31% pre-treatment, and 78.43% and 81.22% post-treatment, respectively. Additionally, the findings showed a similar pattern for the expression level of the ionotropic glutamate receptor genes. Increased extracellular calcium concentrations were also observed, indicating that the presence of vitamin E altered the polarization of astrocytes. In conclusion, α-TCP showed better recovery and prophylactic effects as compared to TRF in the pre-treatment of glutamate-injured primary astrocytes.

Alpha tocopherol is the most common and biologically active form of Vitamin E. The aim of this study was to evaulate the possible antiproliferative effect of alpha tocopherol on F-98 Glioblastoma cells. F-98 glioblastoma cell line was seeded at a density of 50.000/mL per well in 96 well plates in 100 µL medium DMEM. Cells treated with Alpha tocopherol (200,100, 50, 25, 12.5, 6.2, 3.3 µM) for 24 h, 48 h and 72 h incubation. Measurement of Alpha tocopherol treated and control groups’ cell proliferation performed with MTT assay and Wound Healing assay was employed to show migration capacity. MTT Assay data shown are there was significant change in cell viability in 24 h, 48 h and 72 h. However significant decrease was observed at 50, 100 and 200 µM. In the present study, antiproliferative effect of alpha tocopherol was observed via wound healing assay. Our results here show that Alpha Tocopherol maybe a possible avenue for brain cancer treatment.